IPO Observation: Wu Wenting Biological Engineering's IPO Faced Obstacles, and the Company's Financial Risks Are on the Rise
Recently, due to various factors such as the pandemic, the IVD (In Vitro Diagnostic) industry has experienced a surge in listings. In 2019, three IVD companies went public, and in 2020 and 2021, nine